Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 023510/0460 | |
| Pages: | 15 |
| | Recorded: | 11/13/2009 | | |
| Attorney Dkt #: | 042622-0011 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NO. 6613359 TO 6613519 AND TO CORRECT APPLICATION NO. 12262184 TO 12262384 PREVIOUSLY RECORDED ON REEL 022331 FRAME 0074. ASSIGNOR(S) HEREBY CONFIRMS THE INTELLECTUAL PROPERTY SECURITY AGREEMENT. |
|
|
Total properties:
3
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/02/2003
|
Application #:
|
09815016
|
Filing Dt:
|
03/23/2001
|
|
Title:
|
METHOD OF DETERMINING A RISK OF HYPERGLYCEMIC PATIENTS OF DEVELOPING A CARDIOVASCULAR DISEASE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/02/2003
|
Application #:
|
10095669
|
Filing Dt:
|
03/12/2002
|
|
Publication #:
|
|
Pub Dt:
|
12/19/2002
| | | | |
|
Title:
|
METHOD OF USING OPTICALLY-ACTIVATED PARTICLES IN COSMETIC PREPARATIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12262384
|
Filing Dt:
|
10/31/2008
|
|
Publication #:
|
|
Pub Dt:
|
10/01/2009
| | | | |
|
Title:
|
GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2
|
|
|
Assignee
|
|
|
|
|
| 667 MADISON AVENUE, 21ST FLOOR |
| NEW YORK, NEW YORK 10065 |
|
|
Correspondence name and address
|
| |
LATHAM & WATKINS LLP
|
| |
650 TOWN CENTER DRIVE, 20TH FLOOR
|
| |
COSTA MESA, CA 92626
|
Search Results as of:
05/27/2024 01:36 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
